Genenta Science S.p.A.

GNTANasdaq Italy Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$62.682 M

$1.30 -0.76%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

23,432,183

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#120Eloxx PharmaceuticalsELOX$70.9M
#121ImageneBioIMA$64.6M
#122Genenta Science S.p.A.GNTA$62.7M
#123ScilexSCLX$59.0M
#124Inmune BioINMB$55.4M

Where these numbers come from

Share counts and financials for Genenta Science S.p.A. are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.